Abstract

Bismuth (III) oxide nanoparticles’ (Bi2 O3 -NPs) unique physicochemical properties have attracted attention in biological, industrial, technological and medical fields. Concurrently, increasing numbers of studies revealing their potential toxic effects and possible toxicity mechanisms are ongoing. In this study, we assessed the toxic potentials of Bi2 O3 -NPs in human SH-SY5Y neuroblastoma cell line. After Bi2 O3 -NPs characterization using TEM, the cytotoxic potentials were evaluated by MTT and LDH assays. The induction of reactive oxygen species production was evaluated by H2 DCFDA. In order to evaluate the oxidative damages, the changes in antioxidant catalase and superoxide dismutase and glutathione levels were determined. The cellular death pathway and the role of immune response were studied by measuring the mRNA expression levels of related genes. Our results showed that Bi2 O3 -NPs decreased the cell viability through disruption on mitochondrial activity (IC50:77.57 µg/mL) and membrane integrity (LDH%50:16.97 µg/mL). At 50 µg/mL Bi2 O3 -NPs, the production of reactive oxygen species (ROS) was induced significantly as well as the catalase and superoxide dismutase levels. In immune response, the mRNA expression levels of interleukin (IL)-6 increased more than 1.5-fold in all doses; whereas, TNF-α, NF-ĸB and MAPK8 expressions remained unchanged. Consequently, Bi2 O3 -NPs induced oxidative stress-related inflammation via activation of proinflammatory cytokine, IL-6. 

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.